Peritonitis due to Leclercia adecarboxylata in a Patient Receiving Automated Peritoneal Dialysis.
- Author:
Heon Nam LEE
1
;
Jin Woong PARK
;
Hyung Soo KIM
;
Soon Ho PARK
;
Jae Hyun CHANG
;
Woo Kyung CHUNG
;
Hyun Hee LEE
;
Yiel Hae SEO
;
Sejoong KIM
Author Information
1. Department of Internal Medicine, Gachon University of medicine and science, Incheon, Korea. imsejoong@hanmail.net
- Publication Type:Case Report
- Keywords:
Enterobacteriaceae;
Peritoneal dialysis;
Peritonitis
- MeSH:
Anti-Bacterial Agents;
Ascitic Fluid;
Bacillus;
Bacteria;
Catheters;
Diphosphonates;
Enterobacteriaceae;
Humans;
Peritoneal Dialysis;
Peritoneal Dialysis, Continuous Ambulatory;
Peritonitis
- From:Korean Journal of Nephrology
2009;28(6):681-684
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Peritonitis in patients undergoing peritoneal dialysis is a major complication and the leading cause of peritoneal dialysis failure. Leclercia adecarboxylata is a motile, gram-negative, facultative anaerobic bacillus of the Enterobacteriaceae family. These bacteria are uncommon pathogen, and rarely isolated from environmental and clinical specimens. Some cases have been reported about peritonitis due to Leclercia adecarboxylata in a patient receiving continuous ambulatory peritoneal dialysis (CAPD). However, there has never been any report about peritonitis in a patient receiving automated peritoneal dialysis (APD). We have isolated Leclercia adecarboxylata from peritoneal fluid in a patient receiving APD, and the patient completely recovered with 14-day treatment of intraperitoneal antibiotics without catheter removal.
